DRUG
Price
$31.50
Change
-$1.62 (-4.89%)
Updated
Apr 4, 04:57 PM (EDT)
Capitalization
229.85M
MNMD
Price
$5.43
Change
-$0.12 (-2.16%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
418.29M
40 days until earnings call
Ad is loading...

DRUG vs MNMD

Header iconDRUG vs MNMD Comparison
Open Charts DRUG vs MNMDBanner chart's image
Bright Minds Biosciences
Price$31.50
Change-$1.62 (-4.89%)
Volume$200
Capitalization229.85M
Mind Medicine (MindMed)
Price$5.43
Change-$0.12 (-2.16%)
Volume$30.02K
Capitalization418.29M
DRUG vs MNMD Comparison Chart
Loading...
DRUG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MNMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DRUG vs. MNMD commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DRUG is a Hold and MNMD is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (DRUG: $33.12 vs. MNMD: $5.55)
Brand notoriety: DRUG and MNMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DRUG: 58% vs. MNMD: 67%
Market capitalization -- DRUG: $229.85M vs. MNMD: $418.29M
DRUG [@Biotechnology] is valued at $229.85M. MNMD’s [@Biotechnology] market capitalization is $418.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DRUG’s FA Score shows that 0 FA rating(s) are green whileMNMD’s FA Score has 1 green FA rating(s).

  • DRUG’s FA Score: 0 green, 5 red.
  • MNMD’s FA Score: 1 green, 4 red.
According to our system of comparison, both DRUG and MNMD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DRUG’s TA Score shows that 4 TA indicator(s) are bullish while MNMD’s TA Score has 4 bullish TA indicator(s).

  • DRUG’s TA Score: 4 bullish, 5 bearish.
  • MNMD’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both DRUG and MNMD are a bad buy in the short-term.

Price Growth

DRUG (@Biotechnology) experienced а -8.43% price change this week, while MNMD (@Biotechnology) price change was -13.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -10.73%. For the same industry, the average monthly price growth was -16.65%, and the average quarterly price growth was -18.36%.

Reported Earning Dates

DRUG is expected to report earnings on Aug 28, 2023.

MNMD is expected to report earnings on May 14, 2025.

Industries' Descriptions

@Biotechnology (-10.73% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MNMD($418M) has a higher market cap than DRUG($230M). DRUG YTD gains are higher at: -8.051 vs. MNMD (-20.259). DRUG has higher annual earnings (EBITDA): -2.67M vs. MNMD (-105.87M). MNMD has more cash in the bank: 274M vs. DRUG (57.9M). DRUG has less debt than MNMD: DRUG (183K) vs MNMD (21.9M). DRUG (0) and MNMD (0) have equivalent revenues.
DRUGMNMDDRUG / MNMD
Capitalization230M418M55%
EBITDA-2.67M-105.87M3%
Gain YTD-8.051-20.25940%
P/E RatioN/AN/A-
Revenue00-
Total Cash57.9M274M21%
Total Debt183K21.9M1%
FUNDAMENTALS RATINGS
MNMD: Fundamental Ratings
MNMD
OUTLOOK RATING
1..100
74
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
PROFIT vs RISK RATING
1..100
99
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DRUGMNMD
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 8 days ago
85%
Bullish Trend 12 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
DRUG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MNMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JISCX21.35N/A
N/A
Janus Henderson Small Cap Value S
BNUEX10.51N/A
N/A
UBS International Sustainable Equity P
CISIX48.54N/A
N/A
Calvert US Large Cap Core Rspnb Idx I
NQCFX26.09N/A
N/A
NorthQuest Capital
RGPAX20.29N/A
N/A
RBC Global Opportunities A